Stockscreener 앱 받기
17.38
1.86%
-0.33
시간 외 거래:
17.06
-0.32
-1.84%
전일 마감가:
$17.71
열려 있는:
$17.57
하루 거래량:
2.08M
Relative Volume:
1.21
시가총액:
$2.08B
수익:
$59.61M
순이익/손실:
$-262.14M
주가수익비율:
-4.4337
EPS:
-3.92
순현금흐름:
$-247.49M
1주 성능:
+0.52%
1개월 성능:
+10.21%
6개월 성능:
+4.70%
1년 성능:
+71.40%
1일 변동 폭
$17.00
$17.82
1주일 범위
$16.62
$17.88
52주 변동 폭
$8.03
$18.15
Arcutis Biotherapeutics Inc Stock (ARQT) Company Profile
명칭
Arcutis Biotherapeutics Inc
전화
805-418-5006
주소
3027 TOWNSGATE ROAD, WESTLAKE VILLAGE, CA
ARQT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARQT
Arcutis Biotherapeutics Inc
|
17.38 | 2.12B | 59.61M | -262.14M | -247.49M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcutis Biotherapeutics Inc Stock (ARQT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-25 | 개시 | Goldman | Neutral |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-28 | 개시 | Jefferies | Buy |
| 2024-01-03 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-10-26 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2023-10-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-09-07 | 개시 | Needham | Buy |
| 2022-03-17 | 개시 | Goldman | Buy |
| 2021-06-30 | 개시 | Mizuho | Buy |
| 2021-05-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-09 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-10-08 | 개시 | Truist | Buy |
| 2020-02-25 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-02-25 | 개시 | Cowen | Outperform |
| 2020-02-25 | 개시 | Goldman | Neutral |
| 2020-02-25 | 개시 | Guggenheim | Buy |
모두보기
Arcutis Biotherapeutics Inc 주식(ARQT)의 최신 뉴스
Published on: 2025-09-20 11:38:58 - khodrobank.com
Triumph Capital Management Purchases Shares of 29,244 Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Stock Analysis: Is Arcutis Biotherapeutics Inc stock good for income investors2025 Trading Volume Trends & Weekly Chart Analysis and Guides - khodrobank.com
Analyst Upgrade: What is Arcutis Biotherapeutics Inc. s 5 year growth outlookTrade Entry Summary & Community Driven Trade Alerts - khodrobank.com
EPS Watch: Can Viavi Solutions Inc maintain its current growth rateEarnings Risk Report & Weekly High Conviction Trade Ideas - khodrobank.com
Breakout Move: Can Arcutis Biotherapeutics Inc sustain earnings growthJuly 2025 WrapUp & Safe Swing Trade Setup Alerts - khodrobank.com
Arcutis Biotherapeutics (NASDAQ:ARQT) Shares Up 4.5%Time to Buy? - MarketBeat
Take Profit: What are the future prospects of Arcutis Biotherapeutics IncQuarterly Risk Review & Stepwise Trade Execution Plans - خودرو بانک
Anti-Aging Market Surges as $101M Competition Drives Demographic Revolution - Baystreet.ca
Income Plays: Will FBLA face regulatory challengesRecession Risk & Reliable Intraday Trade Alerts - خودرو بانک
Invst LLC Makes New Investment in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Market Review: Is ProShares Trust ProShares UltraPro Short S&P500 a good ESG investmentJuly 2025 WrapUp & Expert-Curated Trade Recommendations - خودرو بانک
CEO Change: Can NanoViricides Inc continue delivering strong returnsWeekly Risk Summary & Safe Entry Zone Tips - خودرو بانک
Arcutis To Present Multiple New ZORYVE® (roflumilast) Data Analyses at European Academy of Dermatology and Venereology Congress - The Manila Times
Arcutis To Present Multiple New ZORYVE® (roflumilast) Data Analyses at European Academy of Dermatology and Venereology Congress | Dow Theory Letters - FinancialContent
Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award - GlobeNewswire
Fred Alger Management LLC Invests $568,000 in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
FOMO Trade: Does Arcutis Biotherapeutics Inc stock reflect fundamentals2025 Sector Review & Low Drawdown Trading Techniques - خودرو بانک
Arcutis Biotherapeutics’ ZORYVE Wins 2025 Allure Best of Beauty Breakthrough Award for Innovation in Dermatology - Quiver Quantitative
Aug Big Picture: Can Arcutis Biotherapeutics Inc stock outperform in a bear market2025 Dividend Review & AI Enhanced Trading Signals - khodrobank.com
Arcutis Biotherapeutics, Inc. (ARQT) Eyes Pediatric Expansion for ZORYVE Cream - MSN
Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Todd Watanabe Sells 9,625 Shares - MarketBeat
Aug Reactions: Will Arcutis Biotherapeutics Inc. benefit from current market trendsMarket Performance Summary & Weekly Top Stock Performers List - khodrobank.com
Chipmakers Recap: Can Arcutis Biotherapeutics Inc sustain earnings growthJuly 2025 Reactions & Reliable Momentum Entry Alerts - khodrobank.com
What are analysts price targets for Arcutis Biotherapeutics Inc2025 Retail Activity & Safe Swing Trade Setup Alerts - khodrobank.com
Fund Flows: What are analysts price targets for Arcutis Biotherapeutics IncQuarterly Investment Review & Daily Profit Maximizing Tips - خودرو بانک
Market Outlook: Is Arcutis Biotherapeutics Inc. forming a bullish divergence2025 Technical Overview & Consistent Income Trade Recommendations - خودرو بانک
Volume Recap: Is Arcutis Biotherapeutics Inc a good stock for dollar cost averagingMarket Performance Summary & Weekly High Momentum Picks - khodrobank.com
Published on: 2025-09-15 14:30:32 - خودرو بانک
Arcutis Biotherapeutics (NASDAQ:ARQT) Sets New 1-Year HighHere's Why - MarketBeat
What MACD signals say about Arcutis Biotherapeutics Inc.2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - newser.com
Arcutis Biotherapeutics Inc. stock trend forecastPortfolio Value Report & Stock Portfolio Risk Control - newser.com
Measuring Arcutis Biotherapeutics Inc.’s beta against major indicesJuly 2025 Final Week & High Accuracy Trade Signal Alerts - newser.com
Arcutis Biotherapeutics Inc. stock volume spike explainedTrade Signal Summary & Smart Swing Trading Alerts - newser.com
Using economic indicators to assess Arcutis Biotherapeutics Inc. potentialPortfolio Return Summary & Safe Entry Momentum Tips - newser.com
Is it time to cut losses on Arcutis Biotherapeutics Inc.2025 Earnings Impact & Consistent Return Investment Signals - newser.com
Scientech Research LLC Takes Position in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells $583,860.80 in Stock - MarketBeat
22,082 Shares in Arcutis Biotherapeutics, Inc. $ARQT Bought by Ieq Capital LLC - MarketBeat
Arcutis Biotherapeutics CEO Watanabe sells $177k in shares By Investing.com - Investing.com South Africa
Arcutis Biotherapeutics CEO Watanabe sells $177k in shares - Investing.com
Arcutis Biotherapeutics Submits Supplemental New Drug Application to FDA For ZORYVE - MSN
Arcutis Biotherapeutics (ARQT) Surges 31% In Last Quarter - Yahoo Finance
Arcutis at H.C. Wainwright: Strategic Growth and Pipeline Development - Investing.com
Arcutis Biotherapeutics Inc (ARQT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.43%
0.09%
자본화:
|
볼륨(24시간):